Dechra announced that, with effect from 1 March 2022, Dr. Lawson Macartney will take up the position as Senior Independent Director following the appointment of Alison Platt as Chair of the Company on 1 January 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,866 GBX | -.--% | -.--% | +0.21% |
06-10 | Dechra Pharmaceuticals Limited Appoints Jonathan David Lang as Director | CI |
04-15 | Dechra Pharmaceuticals Limited acquired 33.34% stake in STEM Animal Health Inc. | CI |
- Stock Market
- Equities
- DPH Stock
- News Dechra Pharmaceuticals
- Dechra Pharmaceuticals plc Announces Executive Changes